Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Marrone Bio Innov (MBII)

Marrone Bio Innov (MBII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Marrone Bio Innov 7780-420 Brier Creek Parkway Raleigh NC 27617 USA

P: 530-750-2800

Description:

Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production, including herbicides for weed control, fungicides for plant disease control, nematicides for parasitic roundworm control, insecticides for insect and mite killers and plant growth regulators that growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. Marrone Bio Innovations Inc. is headquartered in Davis, California.

Key Statistics

Overview:

Market Capitalization, $K 145,556
Enterprise Value, $K 145,578
Shares Outstanding, K 182,378
Annual Sales, $ 44,310 K
Annual Net Income, $ -16,550 K
Last Quarter Sales, $ 11,100 K
Last Quarter Net Income, $ -7,600 K
60-Month Beta 0.36
% of Insider Shareholders 5.00%
% of Institutional Shareholders 68.42%
Float, K 173,259
% Float 95.00%
Short Volume Ratio 0.71

Growth:

1-Year Return -47.84%
3-Year Return -43.80%
5-Year Return -26.10%
5-Year Revenue Growth 215.60%
5-Year Earnings Growth 92.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 05/11/22
Next Earnings Date 08/15/22
Earnings Per Share ttm -0.12
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year -100.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MBII Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.87%
Return-on-Assets % -25.23%
Profit Margin % -37.35
Net Margin % N/A
Debt/Equity 0.33
Price/Sales 4.12
Price/Cash Flow N/A
Price/Book 6.36
Book Value/Share 0.13
Interest Coverage -9.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar